May. 9, 2019—About 35 pounds of over-the-counter and prescription medication were collected on April 12 at a Drug Take Back event hosted by Team Hope, in collaboration with the Tennessee Poison Center and Vanderbilt University Police Department.
May. 9, 2019—VUIIS has partnered with the Vanderbilt University Fine Arts Gallery to scan and create replicas of ancient Mesoamerican artifacts for a hands-on experience in the gallery’s upcoming exhibition.
May. 9, 2019—A new program at Vanderbilt will help researchers determine more precisely how genetic variations contribute to disease and what potentially can be done to put them right.
May. 8, 2019—Vanderbilt's Arie Nettles, PhD, was named as the 2019 recipient of Nashville Cable’s Power of Inclusion Individual Award at a luncheon and ceremony held May 8.
May. 8, 2019—In 1979, Patsy Williams and her brother, Barry Ford, made a decision that has given her many more years of life. Ford gave Williams his kidney at Vanderbilt University Medical Center. They recently gathered for a luncheon to celebrate the 40th anniversary of Williams' transplant, along with dozens of their closest friends and family. She is thought to have lived longer with her transplant than anyone else who received one at Vanderbilt.
May. 7, 2019—Mitchell Edgeworth, MBA, Chief Executive Officer of Vanderbilt University Adult Hospital, has accepted a new position as Chief Administrative Officer — South with the TriStar Division of Hospital Corporation of America, and will be leaving Vanderbilt University Medical Center this month.
May. 3, 2019—Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema.
May. 3, 2019—A roadmap to create an implantable dialysis system that would allow patients to treat kidney failure at home has won researchers from Vanderbilt University Medical Center (VUMC), UC San Francisco (UCSF), and Silicon Kidney one of 15 cash prizes in the inaugural KidneyX’s Redesign Dialysis Phase I competition.
May. 3, 2019—Malignant rhabdoid tumor (MRT) is one of the most aggressive and lethal childhood cancers. Although rare — about 20 to 25 new cases are diagnosed annually in the United States — there is no standard effective treatment for the disease, which is driven by loss of an anti-cancer protein called SNF5. The chances are very small that a child will survive a year after MRT diagnosis.